Zobrazeno 1 - 10
of 17
pro vyhledávání: '"H. J. G. Desirée van den Bongard"'
Autor:
Yasmin A. Civil, Arlene L. Oei, Katya M. Duvivier, Nina Bijker, Philip Meijnen, Lorraine Donkers, Sonja Verheijen, Zdenko van Kesteren, Miguel A. Palacios, Laura J. Schijf, Ellis Barbé, Inge R. H. M. Konings, C. Willemien Menke -van der Houven van Oordt, Paulien G. Westhoff, Hanneke J. M. Meijer, Gwen M. P. Diepenhorst, Victor Thijssen, Florent Mouliere, Berend J. Slotman, Susanne van der Velde, H. J. G. Desirée van den Bongard
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Partial breast irradiation (PBI) is standard of care in low-risk breast cancer patients after breast-conserving surgery (BCS). Pre-operative PBI can result in tumor downstaging and more precise target definition possibly resulting
Externí odkaz:
https://doaj.org/article/dc6a0f20cb054375986fc9996c89d8ed
Autor:
Yasmin A. Civil, Lysanne W. Jonker, Maartje P. M. Groot Koerkamp, Katya M. Duvivier, Ralph de Vries, Arlene L. Oei, Berend J. Slotman, Susanne van der Velde, H. J. G. Desirée van den Bongard
Publikováno v:
Civil, Y A, Jonker, L W, Groot Koerkamp, M P M, Duvivier, K M, de Vries, R, Oei, A L, Slotman, B J, van der Velde, S & van den Bongard, H J G D 2023, ' Preoperative Partial Breast Irradiation in Patients with Low-Risk Breast Cancer : A Systematic Review of Literature ', Annals of Surgical Oncology, vol. 30, no. 6, pp. 3263-3279 . https://doi.org/10.1245/s10434-023-13233-9
Background Preoperative instead of standard postoperative partial breast irradiation (PBI) after breast-conserving surgery (BCS) has the advantage of reducing the irradiated breast volume, toxicity, and number of radiotherapy sessions and can allow t
Autor:
Yasmin A. Civil, Lysanne W. Jonker, Arlene L. Oei, Susanne van der Velde, H. J. G. Desirée van den Bongard
Publikováno v:
Annals of Surgical Oncology. Springer New York
Annals of surgical oncology. Springer New York
Civil, Y A, Jonker, L W, Oei, A L, van der Velde, S & van den Bongard, H J G D 2023, ' ASO Author Reflections : Personalized Breast Cancer Treatment Using Preoperative Partial Breast Irradiation ', Annals of Surgical Oncology . https://doi.org/10.1245/s10434-023-13298-6
Annals of surgical oncology. Springer New York
Civil, Y A, Jonker, L W, Oei, A L, van der Velde, S & van den Bongard, H J G D 2023, ' ASO Author Reflections : Personalized Breast Cancer Treatment Using Preoperative Partial Breast Irradiation ', Annals of Surgical Oncology . https://doi.org/10.1245/s10434-023-13298-6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07b134db4a32f2faaaeb60e4ce311704
https://research.vumc.nl/en/publications/ad3693fc-23ce-44b6-83c1-d40a8b8d3386
https://research.vumc.nl/en/publications/ad3693fc-23ce-44b6-83c1-d40a8b8d3386
Autor:
Ruud M. Pijnappel, Helena M. Verkooijen, Debora Eschbach-Zandbergen, Thijs van Dalen, H J G Desirée van den Bongard, Nienke Hoekstra, Tristan C F van Heijst, Bram van Asselen, Marielle E.P. Philippens, Jan J.W. Lagendijk, Arjen J. Witkamp, Stephanie N de Waard
Publikováno v:
Physics in Medicine and Biology, 62(16), 6746-6761. IOP Publishing Ltd.
Physics in medicine and biology, 62(16), 6746-6761. IOP Publishing Ltd.
Physics in Medicine and Biology, 62(16), 6746. IOP Publishing Ltd.
Physics in medicine and biology, 62(16), 6746-6761. IOP Publishing Ltd.
Physics in Medicine and Biology, 62(16), 6746. IOP Publishing Ltd.
Regional radiotherapy (RT) is increasingly used in breast cancer treatment. Conventionally, computed tomography (CT) is performed for RT planning. Lymph node (LN) target levels are delineated according to anatomical boundaries. Magnetic resonance ima
Autor:
Jan H.M. Schellens, David Critchley, Rolf W. Sparidans, H. J. G. Desirée van den Bongard, Jos H. Beijnen
Publikováno v:
Investigational new drugs, 22(2), 151-158. Kluwer Academic Publishers
E7070 is a novel sulfonamide anticancer agent that arrests cancer cells at the G1/S boundary of the cell cycle. Three patients receiving chronic therapy with the oral anticoagulant acenocoumarol experienced bleeding and/or a prolonged prothrombin tim
Autor:
Willem Boogerd, Jan H.M. Schellens, Jos H. Beijnen, Ron A. A. Mathot, H. J. G. Desirée van den Bongard, Marcel Soesan, Jan H. Schornagel
Publikováno v:
Cancer chemotherapy and pharmacology, 47(6), 537-540. Springer Verlag
A 54-year-old patient with primary cerebral lymphoma was treated with two 4-weekly cycles of high-dose intravenous cytarabine (12 g/m2) and methotrexate (3 g/m2). The administration of the first course proceeded without notable complications. Before
Bayesian pharmacokinetically guided dosing of paclitaxel in patients with non-small cell lung cancer
Autor:
Jan H.M. Schellens, H. J. G. Desirée van den Bongard, Ron A. A. Mathôt, Hilde Rosing, Paul Baas, Jos H. Beijnen, Alwin D. R. Huitema, Milly E de Jonge, Nico van Zandwijk
Publikováno v:
Clinical cancer research, 10(7), 2237-2244. American Association for Cancer Research Inc.
Purpose: Paclitaxel is a taxane derivative with a profound antitumor activity against a variety of solid tumors. In a previous clinical study in patients with non-small cell lung cancer (NSCLC) treated with paclitaxel, it was shown that paclitaxel pl
Autor:
Olaf van Tellingen, Hilde Rosing, Ron A. A. Mathot, Jos H. Beijnen, Jan H.M. Schellens, H. J. G. Desirée van den Bongard, E. Marleen Kemper
Publikováno v:
Analytical biochemistry, 324(1), 11-15. Academic Press Inc.
Paclitaxel is pharmaceutically formulated in a mixture of Cremophor EL and ethanol (1:1, v/v). The unbound fraction of the anticancer drug paclitaxel in plasma is dependent on both plasma protein binding and entrapment in Cremophor EL micelles. We ha
Publikováno v:
Gastrointestinal endoscopy. 55(1)
Background: Patients with malignant esophagorespiratory fistulas have a poor prognosis. Treatment is palliative and involves restoration of the ability to ingest food and prevention of aspiration by insertion of esophageal or tracheobronchial stents.
Autor:
H. J. G. Desirée van den Bongard, Dick Pluim, Jan H.M. Schellens, M. Ravic, Margaret Schot, Hilde Rosing, Lianda G. A. H. Nan-Offeringa, Jos H. Beijnen
Publikováno v:
Anti-cancer drugs, 13(8), 807-814. Lippincott Williams and Wilkins
E7070 is a novel sulfonamide anticancer agent that arrests the G1/S phase of the cell cycle. Preclinical and phase I studies have demonstrated non-linear pharmacokinetics of the drug. The objective of this study was to quantify the excretion of E7070
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f66cf64395055f142bc2fdaf9cd898a6
https://pure.amc.nl/en/publications/an-excretion-balance-and-pharmacokinetic-study-of-the-novel-anticancer-agent-e7070-in-cancer-patients(06e02b22-6a8f-4f1d-9b22-e596ced06960).html
https://pure.amc.nl/en/publications/an-excretion-balance-and-pharmacokinetic-study-of-the-novel-anticancer-agent-e7070-in-cancer-patients(06e02b22-6a8f-4f1d-9b22-e596ced06960).html